1. Rapid, quantitative therapeutic screening for Alzheimer's enzymes enabled by optimal signal transduction with transistors
- Author
-
Curt A. Richter, Arvind Balijepalli, Son T. Le, Antonio Cardone, Michelle A. Morris, Nicholas B. Guros, Harish C. Pant, Brent A. Sperling, and Jeffery B. Klauda
- Subjects
Silicon ,Materials science ,Transistors, Electronic ,High-throughput screening ,FOS: Physical sciences ,Applied Physics (physics.app-ph) ,02 engineering and technology ,Quantitative Biology - Quantitative Methods ,Biochemistry ,Article ,Analytical Chemistry ,law.invention ,03 medical and health sciences ,Alzheimer Disease ,law ,Mesoscale and Nanoscale Physics (cond-mat.mes-hall) ,Electrochemistry ,Humans ,Environmental Chemistry ,Quantitative Methods (q-bio.QM) ,Spectroscopy ,030304 developmental biology ,0303 health sciences ,Condensed Matter - Mesoscale and Nanoscale Physics ,business.industry ,Bandwidth (signal processing) ,Transistor ,Cyclin-Dependent Kinase 5 ,Electrochemical Techniques ,Physics - Applied Physics ,Hydrogen-Ion Concentration ,021001 nanoscience & nanotechnology ,Neuroprotective Agents ,FOS: Biological sciences ,Ph sensing ,Optoelectronics ,Peptides ,0210 nano-technology ,business - Abstract
We show that commercially sourced n-channel silicon field-effect transistors (nFETs) operating above their threshold voltage with closed loop feedback to maintain a constant channel current allow a pH readout resolution of (7.2±0.3)×10(−3) at a bandwidth of 10 Hz, or ≈3-fold better than the open loop operation commonly employed by integrated ion-sensitive field-effect transistors (ISFETs). We leveraged the improved nFET performance to measure the change in solution pH arising from the activity of a pathological form of the kinase Cdk5, an enzyme implicated in Alzheimer’s disease, and showed quantitative agreement with previous measurements. The improved pH resolution was realized while the devices were operated in a remote sensing configuration with the pH sensing element off-chip and connected electrically to the FET gate terminal. We compared these results with those measured by using a custom-built dual-gate 2D field-effect transistor (dg2DFET) fabricated with 2D semi-conducting MoS(2) channels and a signal amplification of 8. Under identical solution conditions the nFET performance approached the dg2DFETs pH resolution of (3.9±0.7)×10(−3). Finally, using the nFETs, we demonstrated the effectiveness of a custom polypeptide, p5, as a therapeutic agent in restoring the function of Cdk5. We expect that the straight-forward modifications to commercially sourced nFETs demonstrated here will lower the barrier to widespread adoption of these remote-gate devices and enable sensitive bioanalytical measurements for high throughput screening in drug discovery and precision medicine applications.
- Published
- 2020